These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 31851158)

  • 1. Bladder-sparing treatment of nonmetastatic muscle-invasive bladder cancer.
    Ericson KJ; Murthy PB; Bryk DJ; Ramkumar RR; Broughman JR; Khanna A; Mian OY; Campbell SC
    Clin Adv Hematol Oncol; 2019 Dec; 17(12):697-707. PubMed ID: 31851158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bladder sparing surgery in high-grade bladder cancer.
    Yakovlev PG; Klyushin DA; Vereshchako RI
    Exp Oncol; 2019 Jun; 41(2):160-165. PubMed ID: 31262149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical analysis of bladder sparing with trimodal therapy in muscle-invasive bladder cancer: a systematic review.
    Ploussard G; Daneshmand S; Efstathiou JA; Herr HW; James ND; Rödel CM; Shariat SF; Shipley WU; Sternberg CN; Thalmann GN; Kassouf W
    Eur Urol; 2014 Jul; 66(1):120-37. PubMed ID: 24613684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Propensity Score Analysis of Radical Cystectomy Versus Bladder-Sparing Trimodal Therapy in the Setting of a Multidisciplinary Bladder Cancer Clinic.
    Kulkarni GS; Hermanns T; Wei Y; Bhindi B; Satkunasivam R; Athanasopoulos P; Bostrom PJ; Kuk C; Li K; Templeton AJ; Sridhar SS; van der Kwast TH; Chung P; Bristow RG; Milosevic M; Warde P; Fleshner NE; Jewett MAS; Bashir S; Zlotta AR
    J Clin Oncol; 2017 Jul; 35(20):2299-2305. PubMed ID: 28410011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective bladder preservation with curative intent for muscle-invasive bladder cancer: a contemporary review.
    Koga F; Kihara K
    Int J Urol; 2012 May; 19(5):388-401. PubMed ID: 22409269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trimodal therapy for invasive bladder cancer: is it really equal to radical cystectomy?
    Mathieu R; Lucca I; Klatte T; Babjuk M; Shariat SF
    Curr Opin Urol; 2015 Sep; 25(5):476-82. PubMed ID: 26125510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical challenges and considerations in Tri-modal therapy for muscle invasive bladder cancer.
    Feldman AS; Kulkarni GS; Bivalacqua TJ; Black PC; Delacroix S; Lerner SP; Kamat AM; Kassouf W
    Urol Oncol; 2022 Oct; 40(10):442-450. PubMed ID: 33642229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bladder Preservation Therapy: Review of Literature and Future Directions of Trimodal Therapy.
    El-Achkar A; Souhami L; Kassouf W
    Curr Urol Rep; 2018 Nov; 19(12):108. PubMed ID: 30392150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trimodal therapy for muscle-invasive bladder cancer.
    Mathes J; Rausch S; Todenhöfer T; Stenzl A
    Expert Rev Anticancer Ther; 2018 Dec; 18(12):1219-1229. PubMed ID: 30324833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing Survival Outcomes and Costs Associated With Radical Cystectomy and Trimodal Therapy for Older Adults With Muscle-Invasive Bladder Cancer.
    Williams SB; Shan Y; Jazzar U; Mehta HB; Baillargeon JG; Huo J; Senagore AJ; Orihuela E; Tyler DS; Swanson TA; Kamat AM
    JAMA Surg; 2018 Oct; 153(10):881-889. PubMed ID: 29955780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The current status of bladder preservation in the treatment of muscle invasive bladder cancer.
    Kim HL; Steinberg GD
    J Urol; 2000 Sep; 164(3 Pt 1):627-32. PubMed ID: 10953112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term Outcomes After Bladder-preserving Tri-modality Therapy for Patients with Muscle-invasive Bladder Cancer: An Updated Analysis of the Massachusetts General Hospital Experience.
    Giacalone NJ; Shipley WU; Clayman RH; Niemierko A; Drumm M; Heney NM; Michaelson MD; Lee RJ; Saylor PJ; Wszolek MF; Feldman AS; Dahl DM; Zietman AL; Efstathiou JA
    Eur Urol; 2017 Jun; 71(6):952-960. PubMed ID: 28081860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radical cystectomy versus organ-sparing trimodality treatment in muscle-invasive bladder cancer: A systematic review of clinical trials.
    Arcangeli G; Strigari L; Arcangeli S
    Crit Rev Oncol Hematol; 2015 Sep; 95(3):387-96. PubMed ID: 25934521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective bladder conservation using transurethral resection, chemotherapy, and radiation: management and consequences of Ta, T1, and Tis recurrence within the retained bladder.
    Zietman AL; Grocela J; Zehr E; Kaufman DS; Young RH; Althausen AF; Heney NM; Shipley WU
    Urology; 2001 Sep; 58(3):380-5. PubMed ID: 11549485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporal Trends and Cancer-Specific Mortality in Nonmetastatic Muscle-Invasive Urothelial Carcinoma of the Urinary Bladder Treated With Trimodal Therapy.
    de Angelis M; Scheipner L; Siech C; Jannello LMI; Baudo A; Bello FD; Goyal JA; Vitucci K; Tian Z; Longo N; Ahyai S; de Cobelli O; Chun FKH; Saad F; Shariat SF; Carmignani L; Gandaglia G; Moschini M; Montorsi F; Briganti A; Karakiewicz PI
    Clin Genitourin Cancer; 2024 Aug; 22(4):102119. PubMed ID: 38852435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Initial results of retrospective study: preoperative transurethral excision plus chemotherapy and radiation therapy and trial of bladder preservation.
    Gamal El-Deen HS
    J Egypt Natl Canc Inst; 2007 Jun; 19(2):133-46. PubMed ID: 19034344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management dilemmas in bladder cancer: radical TUR +/- systemic chemotherapy in the treatment of muscle-invasive bladder cancer.
    Feneley MR; Mellon JK
    Semin Urol Oncol; 2000 Nov; 18(4):300-7. PubMed ID: 11101094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment strategies using transurethral surgery, chemotherapy, and radiation therapy with selection that safely allows bladder conservation for invasive bladder cancer.
    Kanady KE; Shipley WU; Zietman AL; Kaufman DS; Althausen AF; Heney NM
    Semin Surg Oncol; 1997; 13(5):359-64. PubMed ID: 9259092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Outcomes in Patients With Muscle-invasive Bladder Cancer Treated With Radical Cystectomy Versus Bladder Preservation.
    Zhong J; Switchenko J; Jegadeesh NK; Cassidy RJ; Gillespie TW; Master V; Nieh P; Alemozaffar M; Kucuk O; Carthon B; Filson CP; Bilen MA; Jani AB
    Am J Clin Oncol; 2019 Jan; 42(1):36-41. PubMed ID: 29912804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bladder-sparing approaches to invasive disease.
    Efstathiou JA; Zietman AL; Kaufman DS; Heney NM; Coen JJ; Shipley WU
    World J Urol; 2006 Nov; 24(5):517-29. PubMed ID: 17082940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.